眼科手術器械市場報告（2023）：全球市場分析（2022-2028）

最新資訊

本報告提供了有關全球眼科手術器械市場各種可持續發展舉措的最新信息，以及 ESCRS 和 AAO 提出的減少一次性器械造成的手術室廢物的建議。我是。 關於永續發展的新章節強調了製造商面臨的挑戰，並包含了新的指標，可以預測他們的努力將對每個產品類別的未來銷售產生的影響。

該報告結合了手術過程預測和眼科專業的預測。 我們還列出了創建全球主導供應商的最新收購和合併。

本報告對截至 2023 年的全球眼科手術器械市場（可重複使用和一次性）進行了全面分析，並預測了未來五年的市場表現。 它還討論了主要趨勢、市場驅動因素以及未來成功的關鍵因素。 本報告概述了全球眼科手術和數量，以及有關白內障手術（最常進行的眼科手術）提供者的詳細資訊。 從數量和價值方面預測產品需求，並按產品類別分析市場份額。 市場細分包括31家公司的公司概況（產品、策略市場地位、背景、前景等），並列出了與細分市場相關的85家公司。

目錄

本報告旨在為讀者提供對可重複使用和一次性儀器市場趨勢的理解的深度和背景。 內容如下：

• 可重複使用和一次性眼科手術產品概述。
• 可重複使用和一次性眼科手術產品行業的公司簡介。
• 全球白內障發病率和白內障手術統計數據的資訊。
• 全球白內障手術數量的估計和預測（未來五年）。
• 關於屈光水晶體置換手術的考量。
• 有關眼科手術提供者的資訊。
• 美國的 ASC（門診手術中心）和全球白內障手術提供者。
• 世界各地白內障和青光眼治療回顧。
• 世界各地眼科醫生概論。

What's New:

The new "2023 Ophthalmic Surgical Instruments Market Report" provides the latest coverage of various sustainability initiatives and recommendations from the ESCRS and AAO to reduce operating room waste caused by disposable devices. A new chapter on sustainability looks at the challenges that manufacturers face and includes a new rating scale showing the predicted impact of these initiatives on future sales of each product category.

The report connects our surgical procedure forecast by ophthalmic subspecialty to our forecast for surgical instruments. It also lists the latest company acquisitions and consolidations among market competitors that have created globally dominant providers.

The report provides a comprehensive analysis of the 2023 global market for ophthalmic surgical instruments-both reusable and disposable-and forecasts market performance over the next five years. Important trends, market drivers, and key factors for future success are discussed. The report offers an overview of ophthalmic surgeries and surgery volume worldwide, as well as an in-depth look at providers of cataract surgery, the most commonly performed ophthalmic surgery. Product demand is forecast in units and dollars, and market shares are analyzed by product category. The report profiles 31 market competitors-with discussion of their products, strategic market position, background, and outlook-and lists 85 total companies involved in the market segment.

Contents:

The report is designed to provide depth and context to the reader's understanding of market dynamics in the reusable and disposable instrument market. Coverage includes:

• Descriptions of reusable and disposable ophthalmic surgical products.

• Profiles of companies in the reusable and disposable ophthalmic surgical products industry.

• Information on the global incidence of cataracts and global statistics on cataract surgeries.

• Current estimates and five-year forecasts for cataract surgery volume worldwide.

• Discussion of refractive lens exchange procedures.

• Information on ophthalmic surgery providers.

• US ASCs and cataract surgery providers worldwide.

• Review of global cataract and glaucoma treatment methods.

• Global overview of ophthalmologists.

Author Profile:

William Freeman

Bill Freeman has more than 35 years of experience developing, manufacturing, and marketing cataract surgery products. He has held key executive positions at four firms that produce ophthalmic surgical devices.

Bill's career in ophthalmology began in the 1970s. As president of Cavitron Surgical Systems, he worked with Dr. Charles Kelman in developing and marketing the world's first phacoemulsifier system. While highly controversial in the 1970s, phacoemulsification gradually became the preferred cataract removal technique in the early 1980s. For many years, Cavitron led the cataract instrumentation market.

CooperVision purchased Cavitron in the early 1980s, and Bill joined the company as president of the surgical division. CooperVision expanded its product line to include a wide variety of cataract surgical products-IOLs, viscoelastic solutions, disposable devices, lasers, and custom packs-and became the market leader in many product categories.

In 1989, Alcon acquired CooperVision in an effort to build a strong presence in cataract surgical devices. Bill joined Alcon as general manager of the Irvine Technology Center, where a number of the company's cataract devices, including the Legacy 20000 phacoemulsifier and a broad line of disposable items, were designed and manufactured.

Bill remained with Alcon until 1995. He then joined Mentor Ophthalmics as president of the ophthalmology division. At Mentor, he was responsible for the company's ophthalmic products including IOLs, cautery devices, and surgical instruments.

After leaving Mentor in 1999, Bill joined Market Scope in 2000 and now serves as executive vice president focusing on ophthalmic surgical cataract, retinal and glaucoma devices.